New Delhi: Not even a single Indian pharmaceutical company features in the list of world’s top 20 companies that have attempted at making medicines affordable for those in low and middle income countries, revealed a recent study by the Netherlands-based Access to Medicine Foundation.
The Access to Medicine Index lists the top-20 companies in the world on the basis of working towards making available essential drugs in low and middle income countries.
The list is topped by UK-headquartered GlaxoSmithKline. Johnson and Johnson, Novartis, Merck, Sanofi, AstraZeneca, Novo Nordisk, Pfizer, Japanese drug maker Daiichi Sankyo are some of the others who have featured in the top-20 list.
The index focuses on 22 diseases, with major on malaria, HIV/AIDS, tuberculosis and viral hepatitis. Some of the parameters used by the report are pricing, R&D, capacity building, actual performance versus intent and innovation, reports BS.